Zenas BioPharma, Inc. 是一家临床阶段的生物制药公司,致力于开发及商业化变革性免疫学疗法。公司总部位于马萨诸塞州沃尔瑟姆。
财务指标
营业收入
2026-06-30
$100万
2026-03-31
$0
2025-12-31
$1000万
2025-09-30
$0
营业支出
2026-06-30
$1.08亿
2026-03-31
$7734.4万
2025-12-31
$1.82亿
2025-09-30
$4758万
净利润
2026-06-30
-$1.11亿
2026-03-31
-$8098.7万
2025-12-31
-$2.4亿
2025-09-30
-$5149.9万
净利润率
2026-06-30
-11.14K%
2026-03-31
--
2025-12-31
-2.4K%
2025-09-30
--
每股收益
2026-06-30
$-1.77
2026-03-31
$-1.46
2025-12-31
$-1.39
2025-09-30
$-1.22
息税折旧摊销前利润
2026-06-30
-$1.01亿
2026-03-31
-$7435万
2025-12-31
-$2.3亿
2025-09-30
-$5148.8万
有效税率
2026-06-30
-0.1%
2026-03-31
--
2025-12-31
-0.04%
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$100万
$0
$1000万
$0
营业支出
$1.08亿
$7734.4万
$1.82亿
$4758万
净利润
-$1.11亿
-$8098.7万
-$2.4亿
-$5149.9万
净利润率
-11.14K%
--
-2.4K%
--
每股收益
$-1.77
$-1.46
$-1.39
$-1.22
息税折旧摊销前利润
-$1.01亿
-$7435万
-$2.3亿
-$5148.8万
有效税率
-0.1%
--
-0.04%
--
常见问题
ZBIO stock represents shares of ZBIO, a company whose common stock trades on a U.S. exchange under the ticker ZBIO. Owning ZBIO stock means holding a partial ownership stake in the company, giving investors exposure to its business performance. The stock's price reflects supply and demand among market participants. For the latest details on ZBIO's business, listing, and price, refer to the data displayed on this page.
ZBIO stock can be influenced by company-specific developments such as financial results, product or pipeline news, and management decisions. Broader forces, including market sentiment, sector trends, economic conditions, and interest rates, may also move the share price. Because these factors change over time, the latest ZBIO quote and news on this page provide the most current context for understanding recent price action.
Evaluating ZBIO's valuation involves comparing its market price with financial fundamentals and peers. Common approaches include price-to-earnings, price-to-sales, and enterprise-value ratios, alongside growth and profitability trends. Since these metrics depend on current data, use the valuation figures and comparisons displayed on this ZBIO page rather than relying on static numbers. Considering several metrics together generally gives a more complete picture.
To buy ZBIO stock, you typically need a brokerage account that offers access to U.S. exchanges. Once funded, you can place a market or limit order for ZBIO during regular trading hours or, if supported, in extended sessions. Some brokers also allow fractional shares. Confirm the ticker, order type, and any fees before submitting, and check this page for the latest ZBIO quote to inform your order.
Whether ZBIO pays dividends depends on the company's current capital allocation policy. Some companies return cash to shareholders through regular or special dividends, while others retain earnings to fund growth. The most accurate answer for ZBIO appears in the dividend information on this page, including any declared amount, frequency, and history. If no dividend information is shown, ZBIO may not currently pay one.
Investing in ZBIO carries risks that can include business execution challenges, competitive pressure, regulatory or legal changes, and dependence on key products or markets. Financial risks such as rising costs, debt obligations, or weak cash flow may also matter, along with broader market and economic downturns. Reviewing ZBIO's financial statements, filings, and the risk factors on this page can help investors understand these exposures.